Muutke küpsiste eelistusi

E-raamat: Antibody-Drug Conjugates: Methods and Protocols

Edited by
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 122,88 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

 This volume looks at key methodologies that are commonly used across antibody drug conjugates (ADCs) programs. The chapters in this book cover topics such as conjugations to endogenous cysteine residues; click chemistry conjugations; antibody conjugations via glycosyl remodeling; analysis of ADCs by native mass spectrometry; characterization of ADCs by capillary electrophoresis; LC/MS methods for studying lysosomal ADC catabolism; and determination of ADC concentration by ligand-binding assays. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
 
Cutting-edge and practical, Antibody-Drug Conjugates: Methods and Protocols is a valuable resource that aims to lower the “activation barrier” when undertaking a new discipline, and provides a “toolbox” for the next generation of ADC scientists.

Preface v
Contributors ix
1 An Overview of the Current ADC Discovery Landscape
1(22)
L. Nathan Tumey
2 Pushing the Envelope: Advancement of ADCs Outside of Oncology
23(14)
Michael J. Mcpherson
Adrian D. Hobson
3 Conjugations to Endogenous Cysteine Residues
37(14)
Durgesh V. Nadkarni
4 Site-Specific Conjugation to Cys-Engineered Thiomab™ Antibodies
51(20)
Pragya Adhikari
Neelie Zacharias
Rachana Ohri
Jack Sadowsky
5 Transglutaminase-Mediated Conjugations
71(12)
Yasuaki Anami
Kyoji Tsuchikama
6 Click Chemistry Conjugations
83(16)
Tak Ian Chio
Susan L. Bane
7 Utilizing Solid-Phase to Enable High-Throughput, Site-Specific Conjugation and Dual-Labeled Antibody and Fab Conjugates
99(14)
Sujiet Puthenveetil
8 Bridged Cysteine Conjugations
113(18)
Matthew Bird
Joao Nunes
Mark Frigerio
9 Antibody Conjugations via Glycosyl Remodeling
131(16)
Hanna Toftevall
Helen Nyhlen
Fredrik Olsson
Jonathan Sjogren
10 ADC Analysis by Hydrophobic Interaction Chromatography
147(16)
Ryan Fleming
11 Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs
163(24)
Soraya Chapel
Florent Rouviere
Morgan Sarrut
Sabine Heinisch
12 Drug Loading and Distribution of ADCs After Reduction or ideS Digestion and Reduction
187(10)
Elsa Wagner-Rousset
Olivier Colas
Tannis-Nicolas Francois
Sabine Heinisch
Davy Guillarme
Sarah Cianferani
Alain Beck
13 Analysis of ADCs by Native Mass Spectrometry
197(16)
Oscar Hernandez-Alba
Anthony Ehkirch
Alain Beck
Sarah Cianferani
14 High-Resolution Characterization of ADCs by Orbitrap LCMS
213(8)
Jintang He
Surinder Kaur
Keyang Xu
15 Conjugation Site Analysis by MS/MS Protein Sequencing
221(14)
Linjie Han
Tanqun Zhao
Qunying Zhang
16 Conjugation Site Analysis of Lysine-Conjugated ADCs
235(16)
Hua Sang
Ning Wan
Gaoyuan Lu
Tang Tian
Guangji Wang
Hut Te
17 Characterization of ADCs by Capillary Electrophoresis
251(12)
Wenjing Ning
Tanqun Zhao
18 Characterization of the Primary Structure of Cysteine-Linked Antibody-Drug Conjugates Using Capillary Electrophoresis with Mass Spectrometry
263(10)
Josiane Saade
Rabah Gahoual
Alain Beck
Emmanuelle Leize-Wagner
Tannis-Nicolas Francois
19 Purification of ADCs by Hydrophobic Interaction Chromatography
273(18)
Calvin L. Becker
Robert J. Duffy
Jorge Gandarilla
Steven M. Richter
20 Detection and Removal of Small Molecule and Endotoxin Contaminants in ADC Preparations
291(10)
Jeffrey Casavant
Anokha S. Ratnayake
Sujiet Puthenveetil
L. Nathan Tumey
21 Physical Stability Studies of Antibody-Drug Conjugates (ADCs) Under Stressed Conditions
301(12)
Yilma T. Adem
22 Biophysical Methods for Characterization of Antibody-Drug Conjugates
313(16)
Vamsi Krishna Mudhivarthi
Jianxin Guo
23 Determination of ADC Cytotoxicity in Immortalized Human Cell Lines
329(12)
Shengjia Wu
Dhaval K. Shah
24 LC/MS Methods for Studying Lysosomal ADC Catabolism
341(12)
Andrew J. Bessire
Chakrapani Subramanyam
25 Assessing ADC Plasma Stability by LC-MS Methods
353(8)
Cong Wei
26 Determination of ADC Concentration by Ligand-Binding Assays
361(10)
Hsuan-Ping Chang
Dhaval K. Shah
Index 371